This was not only similar to the skeletal changes associated with aberrant USP53 expression in Cantu syndrome but also consistent with the down-regulation of USP53 expression in the bone marrow of osteoporosis patients [84, 85]. The gene discussed is USP53; the disease is hypertrichotic osteochondrodysplasia Cantu type.